UCB SA (UCBJF)
OTCMKTS · Delayed Price · Currency is USD
306.00
-4.61 (-1.48%)
At close: Feb 26, 2026
UCB SA Employees
UCB SA had 8,600 employees as of June 30, 2025. The number of employees decreased by 778 or -8.30% since the number was reported on December 31, 2024.
Employees
8,600
Change
-778
Growth
-8.30%
Revenue / Employee
$1,056,847
Profits / Employee
$212,707
Market Cap
56.75B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Jun 30, 2025 | 8,600 | -778 | -8.30% | 8,600 | 0 |
| Dec 31, 2024 | 9,378 | 295 | 3.25% | 9,052 | 326 |
| Dec 31, 2023 | 9,083 | 380 | 4.37% | 8,450 | 633 |
| Dec 31, 2022 | 8,703 | 142 | 1.66% | 8,108 | 595 |
| Dec 31, 2021 | 8,561 | 190 | 2.27% | 8,006 | 555 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Silence Therapeutics | 116 |
| Vaxart | 105 |
| Northwest Biotherapeutics | 25 |
| CytoDyn | 13 |
| Nuo Therapeutics | 9 |
| ZIVO Bioscience | 7 |
| Vicapsys Life Sciences | 2 |
| Cell Source | 1 |
UCB SA News
- 1 day ago - UCB SA (UCBJY) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 1 day ago - UCB SA 2025 Q4 - Results - Earnings Call Presentation - Seeking Alpha
- 2 days ago - UCB SA Non-GAAP EPS of €9.99, revenue of €7.74B; introduces FY26 outlook - Seeking Alpha
- 10 days ago - Decoding United Community Banks Inc (UCB): A Strategic SWOT Insight - GuruFocus
- 16 days ago - Best Income Stocks to Buy for February 12th - Nasdaq
- 25 days ago - Best Momentum Stocks to Buy for February 3rd - Nasdaq
- 25 days ago - Best Income Stocks to Buy for February 3rd - Nasdaq
- 6 weeks ago - UCB SA (UCBJY) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript - Seeking Alpha